A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database
{{output}}
Tirofiban is a glycoprotein IIb/IIIa receptor blocker mainly used alongside other blood thinners in patients with acute coronary syndrome (ACS) undergoing procedures like angioplasty (PCI). Emerging clinical evidence suggests it may also be beneficial during e... ...
